|By Marketwired .||
|June 20, 2014 06:00 AM EDT||
LONDON, ONTARIO -- (Marketwired) -- 06/20/14 -- Sernova Corp. (TSX VENTURE: SVA), a clinical stage company developing disruptive medical technologies for the long-term treatment of chronic diseases such as diabetes and haemophilia today was featured on BNN by news anchor Francis Horodelski.
Please refer to the segment using the following link:
Sernova Corp. is a clinical stage regenerative medicine company developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including haemophilia and other diseases treated through replacement of proteins or hormones missing or in short supply within the body. Sernova is developing the Cell Pouch, an implantable medical device for therapeutic cells (donor, xenogeneic or stem cells) which then release proteins and/or hormones as required. The therapeutic cells are protected from immune attack by Sernova's proprietary technologies.
This release may contain forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although Sernova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of Sernova's management on the date such statements were made. Sernova expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Skeuomorphism usually means retaining existing design cues in something new that doesn’t actually need them. However, the concept of skeuomorphism can be thought of as relating more broadly to applying existing patterns to new technologies that, in fact, cry out for new approaches. In his session at DevOps Summit, Gordon Haff, Senior Cloud Strategy Marketing and Evangelism Manager at Red Hat, discussed why containers should be paired with new architectural practices such as microservices rathe...
Aug. 29, 2015 06:00 AM EDT Reads: 359
U.S. companies are desperately trying to recruit and hire skilled software engineers and developers, but there is simply not enough quality talent to go around. Tiempo Development is a nearshore software development company. Our headquarters are in AZ, but we are a pioneer and leader in outsourcing to Mexico, based on our three software development centers there. We have a proven process and we are experts at providing our customers with powerful solutions. We transform ideas into reality.
Aug. 29, 2015 05:45 AM EDT Reads: 496
Aug. 29, 2015 05:30 AM EDT Reads: 332
Aug. 29, 2015 05:00 AM EDT Reads: 396
Aug. 29, 2015 03:00 AM EDT Reads: 463
Aug. 28, 2015 11:45 PM EDT Reads: 400
Aug. 28, 2015 11:30 PM EDT Reads: 828
Aug. 28, 2015 09:00 PM EDT Reads: 298
Aug. 28, 2015 07:45 PM EDT Reads: 182
Aug. 28, 2015 06:00 PM EDT Reads: 312
Aug. 28, 2015 05:30 PM EDT Reads: 407
Aug. 28, 2015 03:45 PM EDT Reads: 168
Aug. 28, 2015 03:15 PM EDT
Aug. 28, 2015 03:01 PM EDT
Aug. 28, 2015 02:15 PM EDT Reads: 414